Article Details

Lilly's COVID-19 drug reduces death risk in patients on mechanical ventilation

Retrieved on: 2021-08-03 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Lilly's COVID-19 drug reduces death risk in patients on mechanical ventilation. View article details on hiswai:

Excerpt

... Drug Administration (FDA) first approved Lilly's arthritis drug, baricitinib, in combination with Gilead Sciences' remdesivir, to treat COVID-19 patients.

Article found on: kelo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up